Adjuvant Whole-Brain Radiotherapy After Radiosurgery or Surgical Resection of 1-3 Cerebral Metastases? Results of the EORTC 22952-26001 Study

被引:0
|
作者
Nevinny-Stickel, Meinhard
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:332 / 333
页数:2
相关论文
共 50 条
  • [31] Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients
    Rades, Dirk
    Bohlen, Guenther
    Pluemer, Andre
    Veninga, Theo
    Hanssens, Patrick
    Dunst, Juergen
    Schild, Steven E.
    CANCER, 2007, 109 (12) : 2515 - 2521
  • [32] Whole brain radiotherapy plus stereotactic radiosurgery (WBRT plus SRS) versus surgery plus whole brain radiotherapy (OP plus WBRT) for 1-3 brain metastases: Results of a matched pair analysis
    Rades, Dirk
    Kueter, Jan-Dirk
    Veningla, Theo
    Gliemroth, Jan
    Schild, Steven E.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (03) : 400 - 404
  • [33] Comparison of whole brain radiotherapy (WBRT) alone, WBRT plus stereotactic radiosurgery, and surgery plus WBRT for 1-3 brain metastases
    Rades, D.
    Kueter, J. D.
    Hornung, D.
    Veninga, T.
    Hanssens, P.
    Schild, S. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S199 - S199
  • [34] Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1-3 cerebral metastases
    Schuettrumpf, Lars Hendrik
    Niyazi, Maximilian
    Nachbichler, Silke Birgit
    Manapov, Farkhad
    Jansen, Nathalie
    Siefert, Axel
    Belka, Claus
    RADIATION ONCOLOGY, 2014, 9
  • [35] Stereotactic Radiosurgery for 1-10 Brain Metastases Avoids Whole-Brain Radiotherapy - Results of the CYBER-SPACE Randomized Phase 2 Trial
    El Shafie, R.
    Bernhardt, D.
    Schiele, A.
    Welzel, T.
    Schmitt, D.
    Thalmann, P.
    Erdem, S.
    Paul, A.
    Hoene, S. J.
    Lang, K.
    Koenig, L.
    Weykamp, F.
    Adeberg, S.
    Lentz-Hommertgen, A.
    Jaekel, C.
    Bozorgmehr, F.
    Thomas, M.
    Kieser, M.
    Debus, J.
    Rieken, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (04): : E8 - E8
  • [36] Stereotactic radiosurgery for 1-10 brain metastases to avoid whole-brain radiotherapy: Results of the CYBER-SPACE randomized phase 2 trial
    El Shafie, Rami A.
    Bernhardt, Denise
    Welzel, Thomas
    Schiele, Annabella
    Schmitt, Daniela
    Thalmann, Paul
    Erdem, Sinem
    Paul, Angela
    Hoene, Simon
    Lang, Kristin
    Koenig, Laila
    Weykamp, Fabian
    Adeberg, Sebastian
    Lentz-Hommertgen, Adriane
    Jaekel, Cornelia
    Bozorgmehr, Farastuk
    Nestle, Ursula
    Thomas, Michael
    Sander, Anja
    Kieser, Meinhard
    Debus, Juergen
    Rieken, Stefan
    NEURO-ONCOLOGY, 2024,
  • [37] Relevance of adjuvant whole brain irradiation after local treatment of 1-3 brain metastases of a systemically metastasized malignant melanoma
    Sprave, Tanja
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (12) : 1145 - 1147
  • [38] The Impact of a Central Nervous System Event on Cognitive Function After Volumetric Radiosurgery and Adjuvant Whole-Brain Radiation Therapy in Patients With 1 to 10 Brain Metastases
    Beaton, L. E.
    Ma, R.
    Hsu, F.
    Gondara, L.
    Carolan, H.
    Olson, R. A.
    Schellenberg, D.
    Germain, F.
    Cheung, A. K.
    McKenzie, M.
    Nichol, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E127 - E128
  • [39] Phase II trial of sunitinib as adjuvant therapy after stereotactic radiosurgery in patients with 1-3 newly diagnosed brain metastases
    Ahluwalia, Manmeet S.
    Chao, Samuel T.
    Parsons, Michael W.
    Suh, John H.
    Wang, Ding
    Mikkelsen, Tom
    Brewer, Cathy J.
    Smolenski, Kathy N.
    Schilero, Cathy
    Rump, Matthew
    Elson, Paul
    Angelov, Lilyana
    Barnett, Gene H.
    Vogelbaum, Michael A.
    Weil, Robert J.
    Peereboom, David M.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 124 (03) : 485 - 491
  • [40] Phase 3 international trial of adjuvant whole brain radiotherapy (WBRT) or observation (Obs) following local treatment of 1-3 melanoma brain metastases (MBMs).
    Fogarty, Gerald
    Dolven-Jacobsen, Kari
    Morton, Rachael L.
    Hruby, George
    Nowak, Anna K.
    Vardy, Janette L.
    Drummond, Katharine J.
    Dhillon, Haryana M.
    Mandel, Catherine
    Scolyer, Richard A.
    Shivalingham, Brindha
    Middleton, Mark R.
    Burmeister, Bryan H.
    Lo, Serigne
    Reisse, Claudius H.
    Paton, Elizabeth J.
    Steel, Victoria
    Williams, Narelle C.
    Thompson, John F.
    Hong, Angela M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)